(Información remitida por la empresa firmante)
GOTHENBURG, Sweden, May 4, 2023 /PRNewswire/ -- Zinzino group revenue increased with a total of 20%, compared with the previous year.
The revenue in April for Zinzino's sales markets increased by 22% and amounted to SEK 115.9 (95.0) million. Faun Pharma's external sales decreased by 9% and amounted to SEK 5.3 (5.8) million. Overall, the Group increased revenues by 20% to SEK 121.2 (100.8) million compared with the previous year.
Accumulated revenue for January April 2023 increased by 18% to SEK 514.9 (435.2) million.
Revenues were distributed as follows:
Countries in regions:-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden-Central Europe: Austria, Germany, Switzerland-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey-The Baltics: Estonia, Latvia, Lithuania-North America: Canada, USA-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand-Africa: South Africa
For more information:Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:marketing@zinizno.com
Certified Adviser:Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-april-2023-301816030.html